Spero Therapeutics Inc (SPRO) has fallen 2.23% Monday In Premarket Trading

Monday, March 18, 2024 07:55 AM | InvestorsObserver Analysts

Mentioned in this article

Spero Therapeutics Inc (SPRO) is lower by Monday morning, with the stock decreasing -2.23% in pre-market trading to 1.75. SPRO's short-term technical score of 74 indicates that the stock has traded more bullishly over the last month than 74% of stocks on the market. In the Biotechnology industry, which ranks 99 out of 146 industries, SPRO ranks higher than 86% of stocks. Spero Therapeutics Inc has risen 16.99% over the past month, closing at $1.53 on February 19. During this period of time, the stock fell as low as $1.47 and as high as $1.89. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.

SPRO has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on SPRO!
Spero Therapeutics Inc has a Long-Term Technical rank of 84. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 16% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, SPRO ranks better than 71% of stocks.

Important Dates for Investors in SPRO:

-Spero Therapeutics Inc is set to release earnings on 2024-05-09. Over the last 12 months, the company has reported EPS of $0.39. -We do not have a set dividend date for Spero Therapeutics Inc at this time. Click Here To Get The Full Report on Spero Therapeutics Inc (SPRO)

Share this article: